Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurocognitive and cerebrospinal fluid effects of HAART in adults with HIV infection
NL-OMON33642Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2009
- Countries
- 1
01
Overview
Open-label, single-arm trial in human immunodeficiency virus infection (HIV), sponsored by Radboud University Medical Center. Primary endpoints: Cerebrospinal fluid HIV RNA, Cerebrospinal fluid antiretroviral drug levels and 3 more. Started Apr 2009; status: active, not recruiting.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON33642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33642.